The HHS Office of the Inspector General (OIG) says in its FY 2008 work plan that it will “assess FDA’s oversight and review of allowable off-label drug promotion and enforcement.”
Reps. John Dingell (D-MI), Frank Pallone (D-NJ) and Bart Stupak (D-MI), have introduced the “Food and Drug Import Safety Act of 2007” (HR 3610), which they say will dramatically improve the nation’s system for ensuring the safety of imported food and drugs.
The FDA’s formal public examination of a third class of drugs for the US, between Rx and OTC, sets the stage for a bruising battle between an industry that has always fought the concept and the pharmacy profession which has yearned for it as a professional enhancement long established elsewhere.
Results of a new consumer survey on drug safety released by American University’s Center for Congressional and Presidential Studies indicate that 82% of Americans surveyed trust the FDA on prescription drug issues
PLoS paper says Zoloft literature ghostwritten
November 1, 2007
4:00 am
A paper that ran in PLoS said between 18% and 40% of the medical literature on sertaline (Zoloft) that was published in medical journals between 1998 and 2000 was ghostwritten or managed by a single medical education company acting on behalf of the manufacturer.
FDA launches Drug Safety Newsletter
November 1, 2007
4:00 am
The FDA has launched Drug Safety Newsletter, a quarterly digest of post-marketing drug safety reviews, important emerging drug safety issues and recently approved drugs for healthcare professionals.
Clinician Reviews is relaunching
November 1, 2007
4:00 am
Quadrant Healthcom’s Clinician Reviews is re-launching in January with a tabloid format.
DeSilva + Phillips summit focuses on publishers
November 1, 2007
4:00 am
The DeSilva + Phillips Healthcare Media M&A Summit focused heavily on how publishers are leveraging their offline properties online.
Google to offer viewership data
November 1, 2007
4:00 am
Google plans to offer advertisers more than interactive data.
Pfizer, CDM clean up at Doctors’ Choice
November 1, 2007
4:00 am
Professional ads for Pfizer’s Chantix and Organon’s NuvaRing were the year’s top-rated as judged by physicians in the Association of Medical Media’s fifth annual Doctors’ Choice Awards.
Loading...
MM+M Transform: The Patient, Provider and Payer Engagement Matrix